| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Case of HMGCR-Antibodies Causing Statin-Associated Autoimmune Necrotizing Myopathy
|
Brannick, Ben
|
|
2017
|
11 |
3 |
p. 824-
1 p.
|
artikel
|
| 2 |
A Comparison of the Attainment of Guideline-Recommended LDL-C Lowering With Statin and Ezetimibe+Statin Therapies
|
Toth, Peter P.
|
|
2017
|
11 |
3 |
p. 803-804
2 p.
|
artikel
|
| 3 |
An Electronic Health Records Query for Severe Hypercholesterolemia Identifies Individuals With Undiagnosed Clinical and Molecular FH at a Tertiary Academic Centre
|
Ajufo, Ezim
|
|
2017
|
11 |
3 |
p. 801-
1 p.
|
artikel
|
| 4 |
A Novel Omega-3-Acid Ethyl Ester formulation Incorporating Advanced Lipid Technologies (ALT®) Improves DHA and EPA bioavailability compared with Lovaza
|
Lopez-Toledano, Miguel
|
|
2017
|
11 |
3 |
p. 829-830
2 p.
|
artikel
|
| 5 |
A Patient With Elevated Plasma High Density Lipoprotein (HDL) and Facial Flushing
|
Song, Wenliang
|
|
2017
|
11 |
3 |
p. 794-
1 p.
|
artikel
|
| 6 |
A Phase 1, Single-Dose, Comparative Bioavailability Study of CaPre®, a Novel Omega-3 Drug Candidate, and Lovaza® Under Fasting and Fed Conditions
|
Harvey, Laurent
|
|
2017
|
11 |
3 |
p. 828-
1 p.
|
artikel
|
| 7 |
Apolipoprotein C-III Inhibition With Volanesorsen in Patients With Hypertriglyceridemia (COMPASS): A Randomized, Double-Blind, Placebo-Controlled Trial
|
Gouni-Berthold, Ioanna
|
|
2017
|
11 |
3 |
p. 794-795
2 p.
|
artikel
|
| 8 |
A Practical Office-Based Cholesterol Management System
|
deGoma, Rolando
|
|
2017
|
11 |
3 |
p. 806-807
2 p.
|
artikel
|
| 9 |
A Precision Medicine Blood Test is Associated With Atherosclerotic Plaque Volume By CT-Angiography: Insights From PREDICT and COMPASS Studies
|
Rahmani, Sina
|
|
2017
|
11 |
3 |
p. 776-
1 p.
|
artikel
|
| 10 |
A simplified pathway to proprotein convertase subtilisin/kexin type 9 inhibitor prior authorization approval: A lipid clinic experience
|
Saeed, Anum
|
|
2017
|
11 |
3 |
p. 596-599
4 p.
|
artikel
|
| 11 |
Assessment of pharmacokinetic interaction between omega-3 carboxylic acids and the statins rosuvastatin and simvastatin: Results of 2 phase I studies in healthy volunteers
|
Offman, Elliot
|
|
2017
|
11 |
3 |
p. 739-748
10 p.
|
artikel
|
| 12 |
Association of Elevated Triglycerides and Atherogenic Lipoproteins with Incident Cardiovascular Diseases: Insights from Genetic Data in the Atherosclerosis Risk in Communities Study
|
Saeed, Anum
|
|
2017
|
11 |
3 |
p. 788-
1 p.
|
artikel
|
| 13 |
Baseline Characteristics of a Retrospective Claims Analysis of Cardiovascular Outcomes and Health Care Resource Utilization and Costs in High-Risk Statin-Treated Patients With Hypertriglyceridemia
|
Toth, Peter
|
|
2017
|
11 |
3 |
p. 797-
1 p.
|
artikel
|
| 14 |
Bempedoic Acid Reduces LDL-C and is Well-Tolerated in Patients Receiving Atorvastatin 80 mg Background Therapy
|
McGowan, Mary
|
|
2017
|
11 |
3 |
p. 838-
1 p.
|
artikel
|
| 15 |
Can iPCSK9-induced hypocholesterolemia starve cancer cells?
|
Gangloff, Anne
|
|
2017
|
11 |
3 |
p. 600-601
2 p.
|
artikel
|
| 16 |
Causes of Hypercholesterolemia
|
Schaefer, Ernst
|
|
2017
|
11 |
3 |
p. 772-773
2 p.
|
artikel
|
| 17 |
Challenges in Interpreting Genetic Reports in Familial Hypercholesterolemia: Variants of Uncertain Significance
|
Ueda, Masako
|
|
2017
|
11 |
3 |
p. 790-791
2 p.
|
artikel
|
| 18 |
Characteristics Associated with Prior Authorization Approvals for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in a Medicare Population
|
Sheer, Richard
|
|
2017
|
11 |
3 |
p. 832-
1 p.
|
artikel
|
| 19 |
Characterizing Familial Chylomicronemia Syndrome: Baseline data of the APPROACH Study
|
Blom, Dirk
|
|
2017
|
11 |
3 |
p. 816-
1 p.
|
artikel
|
| 20 |
Cholesterol delivery to the adrenal glands estimated by adrenal venous sampling: An in vivo model to determine the contribution of circulating lipoproteins to steroidogenesis in humans
|
Buitenwerf, Edward
|
|
2017
|
11 |
3 |
p. 733-738
6 p.
|
artikel
|
| 21 |
Clinical and Biochemical Features of Different Molecular Etiologies of Familial Chylomicronemia
|
Hegele, Robert
|
|
2017
|
11 |
3 |
p. 831-832
2 p.
|
artikel
|
| 22 |
Commercial Insurance Approval Rate of Proprotein Convertase Subtlisin Kexin 9 (PCSK9) Inhibitor Prescriptions in a Hospital-Based Lipid Clinic
|
Maciejko, James
|
|
2017
|
11 |
3 |
p. 806-
1 p.
|
artikel
|
| 23 |
Comparison of Two Quantitative Approaches to Diagnose Fredrickson-Levy-Lees Dyslipidemias
|
Sathiyakumar, Vasanth
|
|
2017
|
11 |
3 |
p. 781-782
2 p.
|
artikel
|
| 24 |
Conditions Associated With a History of Extremely Low HDL-C in a US Community Health System
|
Andersen, Lars
|
|
2017
|
11 |
3 |
p. 784-785
2 p.
|
artikel
|
| 25 |
Cost Effective Model for Genomic Screening for Familial Hypercholesterolemia Mutations in Populations With High LDL Cholesterol Levels
|
Fishberg, Robert
|
|
2017
|
11 |
3 |
p. 790-
1 p.
|
artikel
|
| 26 |
Development of Small Molecule Screening Assay for Modulation of Lipoprotein Lipase activity Using Hepatocyte Secretome
|
Venkatesh, Sahana
|
|
2017
|
11 |
3 |
p. 832-834
3 p.
|
artikel
|
| 27 |
Differences in Cholesterol Efflux Capacity Mediated by the ABCA1, ABCG1 and SR-B1 Pathways in Patients With Acute Coronary Syndrome and Stable Coronar
|
Wu, Xing
|
|
2017
|
11 |
3 |
p. 775-776
2 p.
|
artikel
|
| 28 |
Discordance of Low-Density Lipoprotein Cholesterol With Alternate Lipid Measures in Statin-Treated Men and Women With Mixed Dyslipidemia
|
Maki, Kevin
|
|
2017
|
11 |
3 |
p. 774-
1 p.
|
artikel
|
| 29 |
Discordant response of low-density lipoprotein cholesterol and lipoprotein(a) levels to monoclonal antibodies targeting proprotein convertase subtilisin/kexin type 9
|
Edmiston, Jonathan B.
|
|
2017
|
11 |
3 |
p. 667-673
7 p.
|
artikel
|
| 30 |
Durability of Alirocumab Effect: Data From an Open-Label Extension to the ODYSSEY Program for Patients With Heterozygous Familial Hypercholesterolemia
|
Farnier, Michel
|
|
2017
|
11 |
3 |
p. 840-
1 p.
|
artikel
|
| 31 |
Dyslipidemia, Weight Gain, and Decreased Growth Velocity in a 14-Year-Old Male
|
Hamilton, Luke
|
|
2017
|
11 |
3 |
p. 771-772
2 p.
|
artikel
|
| 32 |
Early coronary calcifications are related to cholesterol burden in heterozygous familial hypercholesterolemia
|
Gallo, Antonio
|
|
2017
|
11 |
3 |
p. 704-711.e2
70397 p.
|
artikel
|
| 33 |
Early Follow-up for Patients Identified with Familial Hypercholesterolemia Through a Population Genetic Screening Initiative
|
Jones, Laney
|
|
2017
|
11 |
3 |
p. 811-
1 p.
|
artikel
|
| 34 |
Editorial Board
|
|
|
2017
|
11 |
3 |
p. A1-A4
nvt p.
|
artikel
|
| 35 |
Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients with Elevated Triglycerides(200-499mg/dL)on Statin Therapy(EVAPORATE Study): Rationale and Design
|
Budoff, Matthew
|
|
2017
|
11 |
3 |
p. 799-
1 p.
|
artikel
|
| 36 |
Effects of atorvastatin treatment on left ventricular diastolic function in peritoneal dialysis patients—The ALEVENT clinical trial
|
Wu, Cho-Kai
|
|
2017
|
11 |
3 |
p. 657-666
10 p.
|
artikel
|
| 37 |
Effects of Concomitant Lipid Modifying Therapy on the LDL-C Lowering Efficacy of PCSK-9 Inhibition
|
Abud, Arnold
|
|
2017
|
11 |
3 |
p. 838-839
2 p.
|
artikel
|
| 38 |
Effects of Switching to a Second High Intensity Statin on Low Density Lipoprotein Cholesterol Levels in Clinical Practice in Patients with Clinical Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia
|
Upadhyay, Navneet
|
|
2017
|
11 |
3 |
p. 821-
1 p.
|
artikel
|
| 39 |
Efficacy of Alirocumab Treatment on Lipoproteins At Week 12: Pooled Analyses of 10 ODYSSEY Phase 3 Trials
|
Roth, Eli
|
|
2017
|
11 |
3 |
p. 837-
1 p.
|
artikel
|
| 40 |
Efficacy, Safety, LDL Cholesterol Lowering, and 10-Year ASCVD Risk Reduction: Alirocumab and Evolocumab in Addition to Maximal Tolerated LDL Lowering
|
D'Souza, Kenneth
|
|
2017
|
11 |
3 |
p. 802-
1 p.
|
artikel
|
| 41 |
Eight Week Lifestyle Education Program Improves Concentration on Participants With Reduced Blood Flow to the Brain
|
Ramirez, Francisco
|
|
2017
|
11 |
3 |
p. 824-825
2 p.
|
artikel
|
| 42 |
Elevated Liver Function Tests not from a Statin – A Case History of Garcina Cambogia Associated with Hepato-toxicity
|
Trippi, James
|
|
2017
|
11 |
3 |
p. 823-
1 p.
|
artikel
|
| 43 |
Eligibility for Alirocumab or Evolocumab Treatment in 1090 Hypercholesterolemic Patients Referred to a Regional Cholesterol Treatment Center With LDL Cholesterol ≥70 Mg/Dl Despite Maximal Tolerated Cholesterol Lowering Therapy
|
Goldenberg, Naila
|
|
2017
|
11 |
3 |
p. 786-
1 p.
|
artikel
|
| 44 |
Evaluating the Role of Omega-3 Fatty Acids in Dyslipidemia: Success of Online CME
|
Spyropoulos, Jelena
|
|
2017
|
11 |
3 |
p. 830-831
2 p.
|
artikel
|
| 45 |
Evaluation of Statin Prescribing in Patients With an LDL ≥ 190 mg/dL in an Inner City Teaching Hospital
|
Jones, Julianne
|
|
2017
|
11 |
3 |
p. 812-
1 p.
|
artikel
|
| 46 |
Evaluation of the Use of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors in Statin Intolerant Patients of an Outpatient Lipid Clinic
|
Davidson, Erica
|
|
2017
|
11 |
3 |
p. 822-823
2 p.
|
artikel
|
| 47 |
Extended-Use, Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor (PCSK9i) Data in Patients With Diabetes Mellitus: A Pharmacist-Led Initiative
|
Bizier, Joseph
|
|
2017
|
11 |
3 |
p. 778-
1 p.
|
artikel
|
| 48 |
Extreme hypertriglyceridemia, pseudohyponatremia, and pseudoacidosis in a neonate with lipoprotein lipase deficiency due to segmental uniparental disomy
|
Ashraf, Ambika P.
|
|
2017
|
11 |
3 |
p. 757-762
6 p.
|
artikel
|
| 49 |
Factors Associated with Primary Medication Nonadherence in Patients Prescribed Statins, Ezetimibe, or Statin + Ezetimibe Combination Therapy
|
Hill, Jerrold
|
|
2017
|
11 |
3 |
p. 809-810
2 p.
|
artikel
|
| 50 |
Familial Chylomicronemia Syndrome (FCS): Medical Nutrition Therapy for Patients and Providers
|
Alexander, Lori
|
|
2017
|
11 |
3 |
p. 816-817
2 p.
|
artikel
|
| 51 |
Familial Chylomicronemia Syndrome (FCS) Patients Recruited to the APPROACH Trial of Volanesorsen Therapy are Representative of Subjects with FCS
|
Gaudet, Daniel
|
|
2017
|
11 |
3 |
p. 817-818
2 p.
|
artikel
|
| 52 |
Familial Chylomicron Syndrome: Importance of Discerning the Rare Among the Common
|
Ueda, Masako
|
|
2017
|
11 |
3 |
p. 818-819
2 p.
|
artikel
|
| 53 |
Firefighters on the East and West Coasts Have Increased CHD Risk Associated With Insulin Resistance and Small LDL
|
Superko, H. Robert
|
|
2017
|
11 |
3 |
p. 778-779
2 p.
|
artikel
|
| 54 |
Follow-Up Real-World Data in a Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor Cohort: Results From a Pharmacist-Run Clinic
|
Stryker, Matthew
|
|
2017
|
11 |
3 |
p. 835-836
2 p.
|
artikel
|
| 55 |
From the Editor: The Journal of Clinical Lipidology—2007 to 2017
|
Brown, William Virgil
|
|
2017
|
11 |
3 |
p. 581-585
5 p.
|
artikel
|
| 56 |
Gender Dictates the Relationship Between Clinical Markers of Lipid Metabolism and Immune Function in NHANES 1999-2004
|
Andersen, Catherine
|
|
2017
|
11 |
3 |
p. 787-
1 p.
|
artikel
|
| 57 |
Gene Expression Signature of Platelet Count in Lipoprotein Lipase Deficiency
|
Tremblay, Karine
|
|
2017
|
11 |
3 |
p. 795-
1 p.
|
artikel
|
| 58 |
Genetic Mutation of the LDL-C Receptor without Hypercholesterolemia
|
Jarvis II, Todd
|
|
2017
|
11 |
3 |
p. 791-792
2 p.
|
artikel
|
| 59 |
Glycerophospholipid Fatty Acids GC-MS Analysis in Mice Fed Oxidized Linoleic Acids
|
Ochin, Chinedu
|
|
2017
|
11 |
3 |
p. 826-827
2 p.
|
artikel
|
| 60 |
HDL-Associated Proteins and LDL Differentially Modulate Chronic Myelogenous Leukemia Cell Viability
|
Andersen, Catherine
|
|
2017
|
11 |
3 |
p. 793-794
2 p.
|
artikel
|
| 61 |
Hydrophilic vs lipophilic statins in coronary artery disease: A meta-analysis of randomized controlled trials
|
Bytyçi, Ibadete
|
|
2017
|
11 |
3 |
p. 624-637
14 p.
|
artikel
|
| 62 |
Identification of Cerebrotendinous Xanthomatosis in a Child Presenting With Bilateral Cataracts
|
Duell, P. Barton
|
|
2017
|
11 |
3 |
p. 819-820
2 p.
|
artikel
|
| 63 |
Improving Cardiovascular Risk Prevention in HIV Primary Care
|
Kaplan-Lewis, Emma
|
|
2017
|
11 |
3 |
p. 813-814
2 p.
|
artikel
|
| 64 |
Improving Diagnosis of Familial Chylomicronemia: Success of Online CME
|
Spyropoulos, Jelena
|
|
2017
|
11 |
3 |
p. 808-
1 p.
|
artikel
|
| 65 |
Improving Lipid Management in Clinical Practice: Effect of Online CME
|
Spyropoulos, Jelena
|
|
2017
|
11 |
3 |
p. 808-809
2 p.
|
artikel
|
| 66 |
Increased Prevalence of Clinical and Sub-Clinical Atherosclerosis in Individuals With Damaging Mutations in ABCA1 and APOA1
|
Abdel-Razek, Omar
|
|
2017
|
11 |
3 |
p. 788-789
2 p.
|
artikel
|
| 67 |
Increase in acid sphingomyelinase level in human retinal endothelial cells and CD34+ circulating angiogenic cells isolated from diabetic individuals is associated with dysfunctional retinal vasculature and vascular repair process in diabetes
|
Kady, Nermin
|
|
2017
|
11 |
3 |
p. 694-703
10 p.
|
artikel
|
| 68 |
(In)Equity in Primary Prevention Statin Treatment Among Diabetics
|
Latanich, Christopher
|
|
2017
|
11 |
3 |
p. 805-
1 p.
|
artikel
|
| 69 |
Innovative Teaching Tool to Improve the Understanding of Lipid Risk for the Multidisciplinary Team
|
Mohanram, Anupama
|
|
2017
|
11 |
3 |
p. 807-808
2 p.
|
artikel
|
| 70 |
Instruction for Authors
|
|
|
2017
|
11 |
3 |
p. A10-A11
nvt p.
|
artikel
|
| 71 |
Intensive Lifestyle Interventions Decrease Stroke Risk Factors In 18 Days In Patients With Carotid Stenosis
|
Ramirez, Francisco
|
|
2017
|
11 |
3 |
p. 825-
1 p.
|
artikel
|
| 72 |
Intensive Lifestyle Interventions Improve Isolated Systolic Hypertension
|
Ramirez, Francisco
|
|
2017
|
11 |
3 |
p. 777-778
2 p.
|
artikel
|
| 73 |
Interim Results of the Investigation of Findings and Observations Captured in Burden of Illness Survey in FCS Patients (IN-FOCUS): US Respondents
|
Davidson, Michael
|
|
2017
|
11 |
3 |
p. 804-805
2 p.
|
artikel
|
| 74 |
Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets (IMPACT) Trial Attainment of National Lipid Association Guideline (NLA) Goals
|
Mathews, Tony
|
|
2017
|
11 |
3 |
p. 802-803
2 p.
|
artikel
|
| 75 |
JCL roundtable: Future of the lipid laboratory: Choosing valuable measures among the lipoproteins (part 1)
|
Brown, William Virgil
|
|
2017
|
11 |
3 |
p. 587-595
9 p.
|
artikel
|
| 76 |
Lipid Ageusia: Consequences and Insights on Lipid Detection
|
Alsayyab, Mina
|
|
2017
|
11 |
3 |
p. 822-
1 p.
|
artikel
|
| 77 |
Lipidomic and Proteomic Predictors of Drastic Reductions of HDL in the ACCORD Lipid Trial
|
Khavandi, Maryam
|
|
2017
|
11 |
3 |
p. 792-
1 p.
|
artikel
|
| 78 |
Lipid profile, changes in laboratory prescriptions are necessary
|
Lima-Oliveira, Gabriel
|
|
2017
|
11 |
3 |
p. 768-769
2 p.
|
artikel
|
| 79 |
Lipid profile, the world needs to change
|
Ferreira, Carlos Eduardo dos Santos
|
|
2017
|
11 |
3 |
p. 769-770
2 p.
|
artikel
|
| 80 |
Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project
|
García-Gómez, Carmen
|
|
2017
|
11 |
3 |
p. 749-756.e3
755252 p.
|
artikel
|
| 81 |
Lipoprotein (a) Does Not Adversely Impact Vascular Health in Children with Dyslipidemia
|
Qayum, Omar
|
|
2017
|
11 |
3 |
p. 772-
1 p.
|
artikel
|
| 82 |
Lipoprotein(a) Levels and Age at Onset of Cardiovascular Disease in Family Members of a Pediatric Familial Hypercholesterolemia Population
|
Zawacki, Amy
|
|
2017
|
11 |
3 |
p. 810-811
2 p.
|
artikel
|
| 83 |
Lipoprotein (a) levels and Risk of Cardiovascular Disease Events in Diabetes Mellitus and Prediabetes: The Atherosclerosis Risk in Communities Study
|
Saeed, Anum
|
|
2017
|
11 |
3 |
p. 779-780
2 p.
|
artikel
|
| 84 |
Managing the challenging homozygous familial hypercholesterolemia patient: Academic insights and practical approaches for a severe dyslipidemia, a National Lipid Association Masters Summit
|
Hovingh, G. Kees
|
|
2017
|
11 |
3 |
p. 602-616
15 p.
|
artikel
|
| 85 |
Minimal Food Effect for Eicosapentaenoic Acid and Docosahexaenoic Acid Bioavailability from Omega-3 Acid Ethyl Esters with an ALT based formulation
|
Daak, Ahmed
|
|
2017
|
11 |
3 |
p. 829-
1 p.
|
artikel
|
| 86 |
Multiple symmetric lipomatosis and gynecomastia: A case report and relative literature review
|
Tian, Meimei
|
|
2017
|
11 |
3 |
p. 763-767
5 p.
|
artikel
|
| 87 |
Natural History (up to 15 years) of Platelet Count in 84 Patients with Familial Hyperchylomicronemia Due to Lipoprotein Lipase Deficiency
|
Gaudet, Daniel
|
|
2017
|
11 |
3 |
p. 797-798
2 p.
|
artikel
|
| 88 |
News from the NLA
|
|
|
2017
|
11 |
3 |
p. 586-
1 p.
|
artikel
|
| 89 |
Not Just Pruritic Papules: A Potential Role of AMPK in Hypertriglyceridemia
|
Kataria, Rachna
|
|
2017
|
11 |
3 |
p. 776-777
2 p.
|
artikel
|
| 90 |
Novel protein biomarkers associated with coronary artery disease in statin-treated patients with familial hypercholesterolemia
|
Bos, Sven
|
|
2017
|
11 |
3 |
p. 682-693
12 p.
|
artikel
|
| 91 |
Overcoming Prior Authorization Barriers to PCSK9 Inhibitors with the use of Genetics
|
Graham, Caroline
|
|
2017
|
11 |
3 |
p. 799-800
2 p.
|
artikel
|
| 92 |
Paving the Way for Improved Lysosomal Lipase Deficiency Management: Effect of Online CME
|
Spyropoulos, Jelena
|
|
2017
|
11 |
3 |
p. 809-
1 p.
|
artikel
|
| 93 |
PCSK-9i Gender Study
|
Friedrich, Debra
|
|
2017
|
11 |
3 |
p. 817-
1 p.
|
artikel
|
| 94 |
Pediatric Atherosclerosis Prevention and Lipidology Group Registry
|
Hamilton, Luke
|
|
2017
|
11 |
3 |
p. 820-821
2 p.
|
artikel
|
| 95 |
Pediatric Familial Hypercholesterolemia: Children and Adolescents Enrolled in the CAscade SCreening for Awareness
|
De Ferranti, Sarah
|
|
2017
|
11 |
3 |
p. 812-813
2 p.
|
artikel
|
| 96 |
Plasma Ceramides Predict Residual Cardiovascular Death Risk in Optimally Statin Treated Patients With Stable Coronary Artery Disease
|
Laaksonen, Reijo
|
|
2017
|
11 |
3 |
p. 775-
1 p.
|
artikel
|
| 97 |
Plasma Eicosapentaenoic Acid (EPA) and EPA/AA (Arachidonic Acid) Ratio in a JELIS (Japan EPA Lipid Intervention Study)-like Cohort: Cause for Alarm?
|
Nelson, John
|
|
2017
|
11 |
3 |
p. 783-784
2 p.
|
artikel
|
| 98 |
Plasma EPA and EPA/AA Ratio in Very High Risk Patients with LDL-C <70mg/dl and Non-HDL-C <100mg/dl: Ramifications for Residual Risk and Treatment
|
Nelson, John
|
|
2017
|
11 |
3 |
p. 827-828
2 p.
|
artikel
|
| 99 |
Polygenic Risk Score Predicts Cardiovascular Events in Familial Hypercholesterolemia
|
Baass, Alexis
|
|
2017
|
11 |
3 |
p. 787-788
2 p.
|
artikel
|
| 100 |
Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia
|
Paquette, Martine
|
|
2017
|
11 |
3 |
p. 725-732.e5
7.3199276E7 p.
|
artikel
|
| 101 |
Practice Patterns for Addressing LDL-Cholesterol Levels Below 40 in Patients Receiving Statin Therapy
|
Helsing, Haleigh
|
|
2017
|
11 |
3 |
p. 835-
1 p.
|
artikel
|
| 102 |
Predicting Cardiovascular Events in Familial Hypercholesterolemia: Validation of the Montreal-FH-SCORE
|
Baass, Alexis
|
|
2017
|
11 |
3 |
p. 781-
1 p.
|
artikel
|
| 103 |
Progressive Reduction in LDL Levels Improves Endothelial Cell Nitric Oxide Release and Lowers Oxidative Stress in a Non-Linear Manner
|
Mason, R.
|
|
2017
|
11 |
3 |
p. 831-
1 p.
|
artikel
|
| 104 |
Propofol-Induced Hypertriglyceridemia as a Cause of Stroke
|
Weiss, Matthew
|
|
2017
|
11 |
3 |
p. 798-
1 p.
|
artikel
|
| 105 |
Proprotein convertase subtilisin/kexin 9 inhibition in patients with familial hypercholesterolemia: Initial clinical experience
|
Galema-Boers, Annette M.H.
|
|
2017
|
11 |
3 |
p. 674-681
8 p.
|
artikel
|
| 106 |
Protecting the Gains: What Changes are Needed to Prevent a Reversal of the Downward CVD Mortality Trend?
|
Ortendahl, Jesse
|
|
2017
|
11 |
3 |
p. 782-783
2 p.
|
artikel
|
| 107 |
Real World Adherence to Blood Cholesterol Treatment Guidelines Among Physicians Treating Patients with Atherosclerotic Cardiovascular Disease
|
Ramsaran, Eddison
|
|
2017
|
11 |
3 |
p. 840-841
2 p.
|
artikel
|
| 108 |
Real-World PCSK9i Experience: the Importance of a Multidisciplinary Approach
|
Sathiyakumar, Vasanth
|
|
2017
|
11 |
3 |
p. 803-
1 p.
|
artikel
|
| 109 |
Relationship between long noncoding RNAs and physiological risk factors of cardiovascular disease
|
Mazidi, Moshen
|
|
2017
|
11 |
3 |
p. 617-623
7 p.
|
artikel
|
| 110 |
Relationship of cotinine-verified and self-reported smoking status with metabolic syndrome in 116,094 Korean adults
|
Kim, Byung Jin
|
|
2017
|
11 |
3 |
p. 638-645.e2
63863 p.
|
artikel
|
| 111 |
Retrospective Review of the Effect of Alirocumab on Apheresis
|
Goldberg, Anne
|
|
2017
|
11 |
3 |
p. 834-835
2 p.
|
artikel
|
| 112 |
Safety and Efficacy of Evinacumab, A Monoclonal Antibody to ANGPTL3, In Homozygous Familial Hypercholesterolemia
|
Gaudet, Daniel
|
|
2017
|
11 |
3 |
p. 837-838
2 p.
|
artikel
|
| 113 |
Safety and Efficacy of Sebelipase Alfa Administered for 52 Weeks in Four Male Siblings Diagnosed With Lysosomal Acid Lipase Deficiency
|
Maciejko, James
|
|
2017
|
11 |
3 |
p. 814-
1 p.
|
artikel
|
| 114 |
Salty Hypergeusia Following Lipid Ageusia
|
Alsayyab, Mina
|
|
2017
|
11 |
3 |
p. 821-822
2 p.
|
artikel
|
| 115 |
Sebelipase Alfa Improves Lipid Atherogenic Biomarkers in Children and Adults With Lysosomal Acid Lipase Deficiency
|
Wilson, Don
|
|
2017
|
11 |
3 |
p. 789-790
2 p.
|
artikel
|
| 116 |
Serum triglyceride, high-density lipoprotein cholesterol, apolipoprotein B, and coronary heart disease in a Chinese population undergoing coronary angiography
|
Ling, Yan
|
|
2017
|
11 |
3 |
p. 646-656
11 p.
|
artikel
|
| 117 |
Statin Utilization Patterns Following An Acute Coronary Syndrome (ACS) Event
|
Boklage, Susan
|
|
2017
|
11 |
3 |
p. 805-806
2 p.
|
artikel
|
| 118 |
Subsequent Major Adverse Cardiac Events in Patients With Clinical Atherosclerotic Cardiovascular Disease and Prior Statin Use
|
Boatman, Brian
|
|
2017
|
11 |
3 |
p. 786-
1 p.
|
artikel
|
| 119 |
Table of Contents
|
|
|
2017
|
11 |
3 |
p. A7-A9
nvt p.
|
artikel
|
| 120 |
Team Approach to Prescribing Success for PCSK9 Inhibitors
|
Davis, Tina
|
|
2017
|
11 |
3 |
p. 810-
1 p.
|
artikel
|
| 121 |
The anti-inflammatory function of high-density lipoprotein in type II diabetes: A systematic review
|
Lemmers, Roosmarijn F.H.
|
|
2017
|
11 |
3 |
p. 712-724.e5
7.2399289E7 p.
|
artikel
|
| 122 |
The APPROACH Study: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Volanesorsen Administered Subcutaneously to Patients with Familial Chylomicronemia Syndrome (FCS)
|
Gaudet, D.
|
|
2017
|
11 |
3 |
p. 814-815
2 p.
|
artikel
|
| 123 |
The Clinical and Psychosocial Burden of Patients with Familial Chylomicronemia Syndrome
|
Brown, Alan
|
|
2017
|
11 |
3 |
p. 815-
1 p.
|
artikel
|
| 124 |
The Diagnosis and Treatment of Cerebrotendinous Xanthomatosis
|
Schaefer, Ernst
|
|
2017
|
11 |
3 |
p. 774-775
2 p.
|
artikel
|
| 125 |
The Effect of Dairy Consumption on Lipid Profile: A Meta-Analysis of Randomized Controlled Trials
|
Mitri, Joanna
|
|
2017
|
11 |
3 |
p. 825-826
2 p.
|
artikel
|
| 126 |
The Effects of Aspirin in Combination with EPA and DHA on HDL Cholesterol and HDL-ApoA-I Exchange in Individuals with Type 2 Diabetes Mellitus
|
Holub, Ashley
|
|
2017
|
11 |
3 |
p. 792-793
2 p.
|
artikel
|
| 127 |
The Impact of Fail First Step Therapy on the Care af a Patient With Homozygous Familial Hypercholesterolemia
|
Underberg, James
|
|
2017
|
11 |
3 |
p. 780-
1 p.
|
artikel
|
| 128 |
The Majority of Outpatients With Severe Hypercholesterolemia at an Academic Tertiary Centre Have Not Been Screened for FH
|
Ajufo, Ezim
|
|
2017
|
11 |
3 |
p. 800-801
2 p.
|
artikel
|
| 129 |
The Potential of Electronic Health Record Data to Optimize Recruitment Efficiency in Cardiovascular Outcome Trials
|
Nichols, Gregory
|
|
2017
|
11 |
3 |
p. 796-797
2 p.
|
artikel
|
| 130 |
Treating Hypercholesterolemia with PCSK9 Inhibitors in a Real-World Setting: Twenty Month Experience with Ninety Patients
|
Huth, Glenn
|
|
2017
|
11 |
3 |
p. 839-840
2 p.
|
artikel
|
| 131 |
Treatment of Severe Hypertriglyceridemia (500 to >/= 2000 mg/dL) in 636 Patients
|
Jarman, Michael
|
|
2017
|
11 |
3 |
p. 796-
1 p.
|
artikel
|
| 132 |
Trends in Testing for Lipoprotein(a) at an Academic Medical Center Over 13 Years
|
Wilkinson, Michael
|
|
2017
|
11 |
3 |
p. 773-
1 p.
|
artikel
|
| 133 |
Triglyceride-Lowering Effect of Omega-3 Fatty Acid Ethyl Esters Using Advanced Lipid Technologiestm (ALT®) formulations Under Fasting Conditions
|
Lopez-Toledano, Miguel
|
|
2017
|
11 |
3 |
p. 828-829
2 p.
|
artikel
|
| 134 |
Unmasking of Unsuspected Sitosterolemia by a High Cholesterol Diet Challenge
|
Duell, P. Barton
|
|
2017
|
11 |
3 |
p. 820-
1 p.
|
artikel
|
| 135 |
Using Self-Determination Theory to Distinguish Best and Worst Experiences in LDL Apheresis Treatment among Patients with Familial Hypercholesterolemia
|
Niemiec, Christopher P.
|
|
2017
|
11 |
3 |
p. 800-
1 p.
|
artikel
|
| 136 |
Validation of Electronic Health Records for the Assessment of Statin Dosing In Research
|
Oni-Orisan, Akinyemi
|
|
2017
|
11 |
3 |
p. 836-837
2 p.
|
artikel
|
| 137 |
Value of Clinical Decision Support and Limited Dutch Lipid Clinic Network Criteria In the Diagnosis of Familial Hypercholesterolemia and Premature Coronary Artery Disease
|
Eid, Wael
|
|
2017
|
11 |
3 |
p. 785-786
2 p.
|
artikel
|
Tijdschrift beschrijving